Who
Marc Elia
Chief Executive Officer
Company insider
Files Form 4 as: Chief Executive Officer, Invivyd; Director, Fractyl Health; Director, SQZ Biotechnologies Co.
In numbers
- Trades disclosed
- 14
- Buys
- 3
- Sells
- 0
- Bought
- $12.2M
- Sold
- $0
- Companies
- 3
- Companies where not an officer
- 2
- First trade
- 29 Oct 2020
- Last trade
- 30 Aug 2026
- Last filed
- 1 Sep 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 30 Aug 2026filed 1 Sep 2026 | IVVD Invivydoption or derivative · Biotechnology | SEC FORM 4 Code A | —10,700,000 at $0.00 | filing |
| 30 Aug 2026filed 1 Sep 2026 | IVVD Invivydoption or derivative · Biotechnology | SEC FORM 4 Code A | —10,700,000 at $0.00 | filing |
| 10 Jun 2026filed 11 Jun 2026 | GUTS Fractyl Healthoption or derivative · Medical Devices | SEC FORM 4 Code A | —22,500 at $0.00 | filing |
| 10 Jun 2026filed 11 Jun 2026 | GUTS Fractyl Healthoption or derivative · Medical Devices | SEC FORM 4 Code A | —22,500 at $0.00 | filing |
| 19 May 2026filed 21 May 2026 | IVVD Invivydoption or derivative · Biotechnology | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
| 11 Jun 2025filed 13 Jun 2025 | GUTS Fractyl Healthoption or derivative · Medical Devices | SEC FORM 4 Code A | —22,500 at $0.00 | filing |
| 1 Feb 2024filed 5 Feb 2024 | GUTS Fractyl Healthoption or derivative · Medical Devices | SEC FORM 4 Code A | —45,000 at $0.00 | filing |
| 14 Jun 2023filed 15 Jun 2023 | SQZ Biotechnologies Cooption or derivative | SEC FORM 4 Code A | —39,875 at $0.00 | filing |
| 19 Aug 2022filed 19 Aug 2022 | IVVD InvivydBiotechnology | SEC FORM 4 Bought | $2.7M584,451 at $4.62 | filing |
| 18 Aug 2022filed 19 Aug 2022 | IVVD InvivydBiotechnology | SEC FORM 4 Bought | $5.5M1,265,549 at $4.31 | filing |
| 17 Aug 2022filed 19 Aug 2022 | IVVD InvivydBiotechnology | SEC FORM 4 Bought | $4.0M1,000,000 at $4.04 | filing |
| 15 Jun 2022filed 16 Jun 2022 | SQZ Biotechnologies Cooption or derivative | SEC FORM 4 Code A | —20,000 at $0.00 | filing |
| 15 Jun 2021filed 17 Jun 2021 | SQZ Biotechnologies Cooption or derivative | SEC FORM 4 Code A | —10,500 at $0.00 | filing |
| 29 Oct 2020filed 30 Oct 2020 | SQZ Biotechnologies Cooption or derivative | SEC FORM 4 Code A | —7,055 at $0.00 | filing |
News
Marc Elias' Legal Team Threatens Media With Lawsuit For Questioning Roy Cooper's Healthzerohedge.com · 19 Oct 2026Marc Elias' Legal Team Threatens Media With Lawsuit For Questioning Roy Cooper's Healthzerohedge.com · 19 Oct 2026Marc Elias Legal Team Threatens Media with a Lawsuit for Questioning the Health of Democrat Roy Cooperjonathanturley.org · 16 Oct 2026Democrat Roy Cooper Sends Marc Elias After Reporter for Asking About His Healthbreitbart.com · 14 Oct 2026Mollie Hemingway WRECKS Marc Elias With His Own Pathetic Attempt at Self-Promotion and GRIFTINGtwitchy.com · 13 Oct 2026Left-Wing Lawyer Marc Elias Wants to Pack SCOTUS So It's 'Better.' Here's What He Really Means.townhall.com · 6 Oct 2026BOOM — > Kurt Schlichter DISMANTLES Marc Elias and His Overseas Voter Scare BS With ONE Wordtwitchy.com · 10 Sep 2026Invivyd Presents VMS063, a Potential Best-in-Class Monoclonal Antibody Candidate for the Treatment and Prevention of Measles, at IDWeek 2026IVVD · manilatimes.net · 21 Oct 2026Invivyd (NASDAQ:IVVD) and Arcus Biosciences (NYSE:RCUS) Critical ContrastIVVD · themarketsdaily.com · 19 Oct 2026
7 headlines in the last 90 days name Marc Elia; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.